Presentation is loading. Please wait.

Presentation is loading. Please wait.

Volume 119, Issue 5, Pages (November 2000)

Similar presentations


Presentation on theme: "Volume 119, Issue 5, Pages (November 2000)"— Presentation transcript:

1 Volume 119, Issue 5, Pages 1191-1202 (November 2000)
Primary gastric B-Cell lymphoma: Results of a prospective multicenter study  Wolfgang Fischbach, Brigitte Dragosics, Maria–Elisabeth Kolve–Goebeler, Christian Ohmann, Axel Greiner, Qin Yang, Stephan Böhm, Patrick Verreet, Olaf Horstmann, Martin Busch, Eckhart Dühmke, Hans–Konrad Müller–Hermelink, Klaus Wilms  Gastroenterology  Volume 119, Issue 5, Pages (November 2000) DOI: /gast Copyright © 2000 American Gastroenterological Association Terms and Conditions

2 Fig. 1 Study population. hgNHL, high-grade non-Hodgkin's lymphoma; Hp, H. pylori. *Nonresponder to H. pylori–eradication therapy. Gastroenterology  , DOI: ( /gast ) Copyright © 2000 American Gastroenterological Association Terms and Conditions

3 Fig. 2 Treatment groups in low-grade non-Hodgkin's gastric lymphoma. CS, clinical stage; PS, pathohistologic stage; risk, tumor size > 5 cm, multifocal growth, tumor penetrating the serosa; R0, complete tumor resection; R1, microscopic tumor residuals; R2, macroscopic tumor residuals; Hp, H. pylori; RTx, radiotherapy (30 Gy total abdominal irradiation + 10 Gy or 16 Gy involved field in R0- and R1/R2-resected patients, respectively); L1, L2, L3, treatment groups for intention-to-treat analysis. Gastroenterology  , DOI: ( /gast ) Copyright © 2000 American Gastroenterological Association Terms and Conditions

4 Fig. 3 Treatment groups in high-grade non-Hodgkin's gastric lymphoma. CS, clinical stage; PS, pathohistologic stage; R0, complete tumor resection; R1, microscopic tumor residuals; R2, macroscopic tumor residuals; CTx, chemotherapy (6× CHOP); RTx, radiotherapy (40 Gy involved field); H1, H2, H3, treatment groups for intention-to-treat analysis. Gastroenterology  , DOI: ( /gast ) Copyright © 2000 American Gastroenterological Association Terms and Conditions

5 Fig. 4 (A) Intention-to-treat analysis of low-grade gastric lymphoma. P > 0.05 (log rank test). L1: EI, H. pylori–positive, eradication therapy. L2: EI1, EI2 without risk, R0 resection (including H. pylori–negative, nonresponder to eradication). L3: EI2 with risk, EII, R0 resection; EI/II, R1/R2 resection. (B) Intention-to-treat analysis of high-grade gastric lymphoma. P < (log rank test), H3 vs. H1/H2. H1: EI, R0/R1 resection. H2: EII, R0/R1 resection. H3: EI/II, R2 resection or no surgery/exploratory laparotomy. Gastroenterology  , DOI: ( /gast ) Copyright © 2000 American Gastroenterological Association Terms and Conditions


Download ppt "Volume 119, Issue 5, Pages (November 2000)"

Similar presentations


Ads by Google